Back
Financial Statements
Stock Data
REGN

Regeneron Pharmaceuticals

Health Care
Biotechnology
Tarrytown, New York
Last filing: Feb 4, 2026 (FY2025)
Balance Sheet 13 Accounts • 5 Years
Account 2025 2024 2023 2022 2021
BS_Assets_Cash $0 $2.5B $2.7B $3.1B $2.9B
BS_Assets_AcctsReceivable $0 $6.2B $5.7B $5.3B $6.0B
BS_Assets_Inventory $0 $3.1B $2.6B $2.4B $2.0B
BS_Assets_PPE $0 $4.6B $4.1B $3.8B $3.5B
BS_Assets_IntangibleAssets $0 $1.1B $1.0B $915.5M $0
BS_Assets_OtherNoncurrent $0 $1.1B $444.1M $336.4M $222.8M
BS_Liab_AccruedLiab $0 $571.1M $666.7M $637.5M $383.9M
BS_Liab_OtherCurrent $0 $213.2M $0 $0 $326.3M
BS_Liab_LongTermDebt $0 $2.0B $2.0B $2.0B $2.0B
BS_Liab_OtherNoncurrent $0 $1.6B $854.1M $638.0M $680.2M
BS_Equity_PreferredStock $0 $0 $0 $0 $0
BS_Equity_CommonStock $0 $0 $0 $0 $0
BS_Equity_TreasuryStock $0 $15.2B $12.6B $10.4B $8.3B